| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 33,135,000 | 40,736,000 | 45,417,000 | 31,188,000 | | Cost of Revenue | 3,194,000 | 2,082,000 | 2,543,000 | 3,296,000 | | | Gross Profit |
-
| 38,654,000 | 42,874,000 | 27,892,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,202,000 | 15,675,000 | 15,717,000 | 10,164,000 | | Non Recurring | 594,000 | 829,000 | 765,000 | 306,000 | | Others | 12,215,000 | 13,891,000 | 13,900,000 | 16,024,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 8,259,000 | 12,492,000 | 1,398,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,414,000 | 8,259,000 | 12,492,000 | 1,398,000 | | Interest Expense | 3,906,000 | 5,880,000 | 7,116,000 | 5,200,000 | | Income Before Tax | (1,976,000) | 2,379,000 | 5,376,000 | (3,802,000) | | Income Tax Expense | (975,000) | (845,000) | 1,129,000 | (2,013,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,987,000 | 3,224,000 | 4,247,000 | (1,789,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,001,000) | 3,224,000 | 4,247,000 | (1,789,000) | | Preferred Stock And Other Adjustments | (1,240,000) | (805,000) | (1,433,000) | (603,000) | | | Net Income Applicable To Common Shares | ($2,241,000) | $2,419,000 | $2,814,000 | ($2,392,000) |
|
0.02% Nasdaq 0.00%
Income Statement
